Sicart Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,200
| Closed | -$212K | – | 72 |
|
|
2023
Q1 | $212K | Hold |
5,200
| – | – | 0.08% | 64 |
|
|
2022
Q4 | $266K | Buy |
5,200
+310
| +6% | +$15.9K | 0.09% | 64 |
|
|
2022
Q3 | $214K | Buy |
4,890
+560
| +13% | +$24.5K | 0.08% | 71 |
|
|
2022
Q2 | $227K | Sell |
4,330
-1,175
| -21% | -$61.6K | 0.07% | 74 |
|
|
2022
Q1 | $285K | Sell |
5,505
-248,090
| -98% | -$12.8M | 0.07% | 73 |
|
|
2021
Q4 | $14.8M | Sell |
253,595
-1,250
| -0.5% | -$73K | 3.87% | 7 |
|
|
2021
Q3 | $11M | Sell |
254,845
-22,560
| -8% | -$970K | 2.99% | 10 |
|
|
2021
Q2 | $10.9M | Buy |
277,405
+117,450
| +73% | +$4.6M | 2.59% | 14 |
|
|
2021
Q1 | $5.8M | Sell |
159,955
-4,584
| -3% | -$166K | 1.53% | 23 |
|
|
2020
Q4 | $6.06M | Buy |
164,539
+25,734
| +19% | +$947K | 1.5% | 24 |
|
|
2020
Q3 | $4.83M | Sell |
138,805
-533
| -0.4% | -$18.6K | 1.44% | 21 |
|
|
2020
Q2 | $4.32M | Sell |
139,338
-1,075
| -0.8% | -$33.4K | 1.38% | 21 |
|
|
2020
Q1 | $4.35M | Buy |
140,413
+120,667
| +611% | +$3.74M | 1.66% | 17 |
|
|
2019
Q4 | $734K | Buy |
19,746
+422
| +2% | +$15.7K | 0.24% | 54 |
|
|
2019
Q3 | $659K | Sell |
19,324
-28,069
| -59% | -$957K | 0.22% | 58 |
|
|
2019
Q2 | $1.95M | Buy |
47,393
+316
| +0.7% | +$13K | 0.79% | 31 |
|
|
2019
Q1 | $1.9M | Hold |
47,077
| – | – | 0.8% | 30 |
|
|
2018
Q4 | $1.95M | Hold |
47,077
| – | – | 0.94% | 27 |
|
|
2018
Q3 | $1.97M | Hold |
47,077
| – | – | 0.94% | 26 |
|
|
2018
Q2 | $1.62M | Hold |
47,077
| – | – | 0.85% | 30 |
|
|
2018
Q1 | $1.59M | Hold |
47,077
| – | – | 0.95% | 28 |
|
|
2017
Q4 | $1.62M | Buy |
47,077
+21,080
| +81% | +$725K | 0.85% | 36 |
|
|
2017
Q3 | $881K | Buy |
25,997
+295
| +1% | +$10K | 0.63% | 39 |
|
|
2017
Q2 | $819K | Hold |
25,702
| – | – | 0.6% | 38 |
|
|
2017
Q1 | $834K | Sell |
25,702
-54,281
| -68% | -$1.76M | 0.6% | 39 |
|
|
2016
Q4 | $2.47M | Buy |
+79,983
| New | +$2.47M | 1.7% | 16 |
|